You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
澳洲批准使用辉瑞疫苗 料下月底开始接种
阿思达克 01-25 14:22
澳洲药物管理局(TGA)批准辉瑞(PFE.US)与BioNTech(BNTX.US)研发的新冠病毒疫苗在澳洲使用,为澳洲首款批准使用的新冠疫苗,首剂疫苗预计将在下月底注射。

澳洲总理莫理逊表示,当局是根据正常的药管局程序发出正式批准,而不是紧急批准。政府希望健康护理和老人院舍工人等获优先使用疫苗的人士,可在2月底开始接种疫苗,但承认有可能出现运送和生产的延误,令接种工作推迟至3月初。

莫理逊又指,澳洲有能力在本地生产辉瑞疫苗,一旦生产线搬至澳洲後,每星期可生产达100万剂。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account